Masimo Corporation (MASI)
| Market Cap | 7.25B |
| Revenue (ttm) | 2.05B |
| Net Income (ttm) | 81.50M |
| Shares Out | 52.91M |
| EPS (ttm) | 1.51 |
| PE Ratio | 90.70 |
| Forward PE | 39.42 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 317,033 |
| Open | 134.43 |
| Previous Close | 134.32 |
| Day's Range | 134.43 - 138.18 |
| 52-Week Range | 75.22 - 195.82 |
| Beta | 0.98 |
| Analysts | Buy |
| Price Target | 146.80 (+7.19%) |
| Earnings Date | May 7, 2024 |
About MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional... [Read more]
Financial Performance
In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $146.8, which is an increase of 7.19% from the latest price.
News
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The confe...
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
SANTIAGO, Chile--(BUSINESS WIRE)--Masimo CEO Joe Kiani will speak at the Global Ministerial Summit on Patient Safety in Chile about how AI-based solutions can improve patient safety.
Masimo To Explore Spin-Off Of Its Consumer Unit
On March 22, 2024, Masimo MASI Corporation, a global leader in non-invasive monitoring technologies and audio products, announced that its Board of directors had authorized management to evaluate a pr...
Masimo Responds to Politan Capital's Nomination of Director Candidates and Refutes Politan's False Claims
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election...
Masimo CEO on potential split, proxy battle and spinning off consumer business
Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss the company spinning off its consumer business.
Masimo May Look at Joint Venture for Consumer Split, CEO Says
The medical-device maker has been approached by a potential joint venture partner, CEO Joe Kiani said.
Activist investor plans second fight at Masimo, sending shares up 12%
Quentin Koffey's Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more board seats.
Politan Nominates Two Independent Candidates for Masimo Board
NEW YORK--(BUSINESS WIRE)--Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today announced t...
Masimo's stock rallies on report of looming activist campaign, disclosure of spinoff plan
Masimo Corp.'s stock MASI, +1.40% was up 12% in premarket trading on Monday after The Wall Street Journal reported that activist investor Politan Capital Management plans to nominate two more members ...
Masimo Stock Surges After Proposed Spinoff of Consumer Business
Share in Masimo (MASI) surged 13% in extended trading on Friday after the company announced that it is planning a spinoff of its consumer unit to improve the profitability of its primary healthcare bu...
Activist Politan Plans Second Proxy Battle at Masimo
Politan Capital Management, founded by veteran activist Quentin Koffey, plans to nominate two director candidates to the company's six-person board.
Activist investor Politan plans second proxy battle at Masimo, WSJ reports
Activist investor Politan Capital Management, which last year won two seats on the board of medical technology company Masimo Corp , is planning a second proxy battle for two more seats, the Wall Stre...
Masimo to Separate Consumer Business
The Irvine, Calif.-based medical technology company expects the separation to include its consumer audio and consumer health products.
Masimo plans to spinoff consumer business
Medical technology company Masimo Corp said on Friday it is evaluating a proposed spinoff of its consumer business, which includes its consumer health and audio products, sending shares up 13% in exte...
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management...
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 202...
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 30, 2023. Fourth Quarter 2023 Results: Consolidated rev...
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
IRVINE, Calif. & DENVER--(BUSINESS WIRE)--Masimo and UCHealth are entering into a strategic collaboration to improve patient care using the latest in virtual care and telehealth capabilities.
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
IRVINE, Calif.--(BUSINESS WIRE)--A new study has found that Masimo RD SET® pulse oximetry sensors accurately measure SpO2 on both Black and White subjects even when perfusion is low.
Masimo CEO: Would Be Happy With Win-Win Apple Settlement
Apple will begin selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the US, following a legal setback in its patent dispute with Masimo. Masimo CEO Joseph Kiani joi...
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
IRVINE, Calif.--(BUSINESS WIRE)--The Federal Circuit has lifted the temporary stay on the import ban of certain Apple Watch models.
Ex-Disney Chief Bob Chapek Appointed To Board Of Medical Firm Masimo As Company Battles Apple
Bob Chapek, a nearly three-decade Disney veteran who was ousted in 2022 as the media company's CEO, has been appointed to the board of directors of medical tech firm Masimo. The move comes during a dr...
Masimo Announces New Member of the Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo's Board of Directors. Mr. Chapek was Chief Executive Officer of The Walt Disney Comp...
U.S. appeals court upholds tribunal decisions in Apple-Masimo patent dispute
A U.S. appeals court on Friday upheld two earlier decisions by a patent tribunal that favored Masimo in its intellectual property dispute with Apple over blood oxygen sensors in newer Apple Watch mode...
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
IRVINE, California--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided es...